Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(1.76)
# 3,301
Out of 5,056 analysts
207
Total ratings
22.49%
Success rate
-5.98%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.04 | +765.38% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $8 | $0.50 | +1,506.75% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $4.92 | +286.18% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $1.58 | +153.16% | 7 | Apr 8, 2025 | |
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $3.26 | -38.65% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $8 | $0.49 | +1,540.69% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $2.64 | +619.70% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $1.79 | +1,073.18% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $1.25 | +1,100.00% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $560 | $4.20 | +13,233.33% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $120 | $5.98 | +1,906.69% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $6.59 | +506.98% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $1.80 | +1,566.67% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $7.20 | +163.89% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $1.89 | +746.56% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.94 | +537.35% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.11 | +8,949.77% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.39 | +4,548.76% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.06 | +870.87% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $6.26 | +251,497.44% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $16.01 | +3,023.05% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $31.00 | +674.19% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.42 | +5,548.12% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,500 | $6.74 | +22,155.19% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $6.99 | +114,349.21% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.24 | +464.52% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $1.79 | +1,575.98% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $4.72 | +747.46% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $6.74 | +167.06% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $5.83 | -14.24% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | $10.68 | +13,383.15% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $65.94 | -63.60% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $1.15 | +297,291.30% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $1.07 | +1,775,600.93% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.04
Upside: +765.38%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $8
Current: $0.50
Upside: +1,506.75%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $4.92
Upside: +286.18%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $1.58
Upside: +153.16%
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $3.26
Upside: -38.65%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $8
Current: $0.49
Upside: +1,540.69%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $2.64
Upside: +619.70%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $1.79
Upside: +1,073.18%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.25
Upside: +1,100.00%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $560
Current: $4.20
Upside: +13,233.33%
Mar 6, 2025
Reiterates: Buy
Price Target: $120
Current: $5.98
Upside: +1,906.69%
Mar 5, 2025
Reiterates: Buy
Price Target: $40
Current: $6.59
Upside: +506.98%
Mar 4, 2025
Reiterates: Buy
Price Target: $30
Current: $1.80
Upside: +1,566.67%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $7.20
Upside: +163.89%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $1.89
Upside: +746.56%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $0.94
Upside: +537.35%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $1.11
Upside: +8,949.77%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $0.39
Upside: +4,548.76%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.06
Upside: +870.87%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $6.26
Upside: +251,497.44%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $16.01
Upside: +3,023.05%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $31.00
Upside: +674.19%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $1.42
Upside: +5,548.12%
Jun 30, 2021
Initiates: Buy
Price Target: $1,500
Current: $6.74
Upside: +22,155.19%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $6.99
Upside: +114,349.21%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.24
Upside: +464.52%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $1.79
Upside: +1,575.98%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $4.72
Upside: +747.46%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $6.74
Upside: +167.06%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $5.83
Upside: -14.24%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: $10.68
Upside: +13,383.15%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $65.94
Upside: -63.60%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $1.15
Upside: +297,291.30%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $1.07
Upside: +1,775,600.93%